[Influencing of mitosis rate in endometrial carcinomas using 17-hydroxynorprogesterone capronate in women].
作者信息
Kaiser R, Schneider E
出版信息
Arch Gynakol. 1972;212(4):397-400. doi: 10.1007/BF00667725.
PMID:4678917
Abstract
摘要
相似文献
1
[Influencing of mitosis rate in endometrial carcinomas using 17-hydroxynorprogesterone capronate in women].
Arch Gynakol. 1972;212(4):397-400. doi: 10.1007/BF00667725.
2
The effects of progesterone and progestins on endometrial proliferation.孕酮和孕激素对子宫内膜增殖的影响。
Contraception. 1998 Jun;57(6):399-403. doi: 10.1016/s0010-7824(98)00047-x.
3
Do estrogen and progesterone receptors (E2R and PR) in metastasizing endometrial cancers predict the response to gestagen therapy?转移性子宫内膜癌中的雌激素和孕激素受体（E2R和PR）能否预测对孕激素治疗的反应？
Acta Obstet Gynecol Scand. 1980;59(2):155-9. doi: 10.3109/00016348009154633.
4
[Adjuvant gestagen therapy of endometrial carcinoma (author's transl)].子宫内膜癌的辅助孕激素治疗（作者译）
Zentralbl Gynakol. 1981;103(21):1289-93.
5
Progestogen treatment of recurrent endometrial carcinoma.复发性子宫内膜癌的孕激素治疗
Am J Obstet Gynecol. 1971 May 1;110(1):15-23. doi: 10.1016/0002-9378(71)90207-9.
6
[Gestagen treatment of endometrial carcinoma--theoretical and practical application].[孕激素治疗子宫内膜癌——理论与实际应用]
Gan To Kagaku Ryoho. 1984 May;11(5):1005-11.
7
Cytosol oestradiol and progesterone receptors in endometrial hyperplasia and adenocarcinoma: determination by single saturating dose exchange assays.子宫内膜增生和腺癌中胞质雌二醇和孕酮受体：通过单次饱和剂量交换测定法进行测定
Aust N Z J Obstet Gynaecol. 1980 Nov;20(4):199-204. doi: 10.1111/j.1479-828x.1980.tb00764.x.
8
9
The morphologic response of the human endometrium to long-term treatment with progestational agents.
Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):796-808. doi: 10.1016/s0002-9378(16)32491-7.
10
[Results of high dosage progesterone therapy in carcinoma corporis uteri].[高剂量孕酮治疗子宫体癌的结果]
Zentralbl Gynakol. 1977;99(7):392-5.
引用本文的文献
1
[Mitosis rate in endometrial carcinomas of the woman following estrogen administration].[给予雌激素后该女性子宫内膜癌的有丝分裂率]
Arch Gynakol. 1972;213(1):28-30. doi: 10.1007/BF00668110.
本文引用的文献
1
[On gestagen therapy of advanced corpus uteri cancer].
Geburtshilfe Frauenheilkd. 1968 May;28(5):417-27.
2
Progestogen treatment of recurrent endometrial carcinoma.复发性子宫内膜癌的孕激素治疗
Am J Obstet Gynecol. 1971 May 1;110(1):15-23. doi: 10.1016/0002-9378(71)90207-9.
Zotero 插件